David Kossler

David Kossler is currently a Principal Scientist at Roche, where they lead pCMC projects and develop scalable synthetic routes for early toxicological and clinical campaigns. Prior to this role, Kossler served as a Senior Scientist at Roche and as a Scientist in the API Small Molecules department at The Janssen Pharmaceutical Companies of Johnson & Johnson. Kossler completed a PhD in Organic Chemistry at the École polytechnique fédérale de Lausanne and conducted postdoctoral research at The Scripps Research Institute, focusing on natural product synthesis. Kossler continues their education at Heidelberg University, pursuing a Diploma in Chemistry.